Skip to Content

Join the 'Glaucoma' group to help and get support from people like you.

Glaucoma News

Diabetes Drug Metformin May Lower Glaucoma Risk

Posted 28 May 2015 by

THURSDAY, May 28, 2015 – The diabetes drug metformin was linked to a lower risk of developing the eye condition glaucoma in a new study. People who took the most metformin during the 10-year study period had a 25 percent reduced risk of glaucoma compared with people not taking the drug, researchers found. "Glaucoma is a leading cause of blindness worldwide and classic open-angle glaucoma develops in late middle age or late age. So we hypothesized that a drug that mimics caloric restriction, such as metformin, might reduce the risk of glaucoma," said lead researcher Julia Richards, a professor of ophthalmology and visual sciences at the University of Michigan in Ann Arbor. Exactly how metformin might reduce the risk of glaucoma isn't known, the researchers said. And, while this study found an association between metformin use and lower glaucoma risk, it wasn't designed to prove a ... Read more

Related support groups: Metformin, Glaucoma, Glucophage, Janumet, Glucophage XR, ActoPlus Met, Glumetza, Glyburide/Metformin, Glaucoma/Intraocular Hypertension, Jentadueto, Avandamet, Glucovance, Janumet XR, Kombiglyze XR, Metformin/Pioglitazone, Fortamet, Metformin/Sitagliptin, Riomet, Glipizide/Metformin, ActosPlus Met

Lupin Receives FDA Approval for Generic Lumigan Ophthalmic Solution 0.03%

Posted 23 Feb 2015 by

Mumbai, India and Baltimore, Maryland – February 23, 2015: Pharma Major Lupin Limited (Lupin) announced today that it has received final approval for its Bimatoprost Ophthalmic Solution, 0.03% from the United States Food and Drugs Administration (FDA) to market a generic version of Allergan Inc.'s Lumigan Ophthalmic Solution, 0.03%. Lupin Pharmaceuticals Inc. (LPI), the company's U.S. subsidiary would commence marketing the product shortly. Lupin's Bimatoprost Ophthalmic Solution, 0.03% is the AT rated generic equivalent of Lumigan Ophthalmic Solution, 0.03% and is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. Lupin's Bimatoprost Ophthalmic Solution, 0.03% filing was made from its Indore facility which was audited in January, 2015. Two Lupin facilities, the Lupin Bioresearch Center, Pune (LBC) and its ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Lumigan, Glaucoma/Intraocular Hypertension, Bimatoprost

Generic Eye Drops for Glaucoma Encourage Greater Use

Posted 19 Feb 2015 by

THURSDAY, Feb. 19, 2015 – Glaucoma patients are more likely to take medications to treat their eye disease if they're prescribed generic drugs, a new study finds. More than half of Americans with glaucoma do not take their medications as prescribed, which is one of the biggest obstacles in efforts to prevent glaucoma-related blindness, according to the researchers. Open-angle glaucoma is the most common form of the disease in the United States. It's treated with drugs called prostaglandin analogue (PGA) eye drops. These drugs are very effective, but brand name PGAs tend to be significantly more costly than other types of glaucoma drugs. A generic version of the PGA latanoprost was approved by the U.S. Food and Drug Administration in 2011 and at the time was $1,300 cheaper per year than brand name PGAs. In this study, researchers analyzed data from more than 8,400 glaucoma patients. All ... Read more

Related support groups: Glaucoma, Xalatan, Latanoprost

High Blood Pressure May Boost Glaucoma Risk

Posted 8 Jan 2015 by

WEDNESDAY, Jan. 7, 2015 – Long-term high blood pressure may increase the risk of the eye disease glaucoma, according to a new study. The researchers said their findings suggest that doctors should consider a patient's blood pressure when managing glaucoma, the second leading cause of blindness in the world. Glaucoma occurs when excessive pressure inside the eye pushes back against blood trying to enter the eye. It had been thought that because high blood pressure (hypertension) ensures that blood can enter the eye, it could counteract the high eye pressure that causes glaucoma. However, this study of short-term (one hour) and long-term (four weeks) high blood pressure in rats with elevated eye pressure found that long-term high blood pressure actually increases the risk of glaucoma. The study was published recently in the journal Investigative Ophthalmology & Visual Science. "When we ... Read more

Related support groups: High Blood Pressure, Hypertension, Glaucoma

Study Supports Benefit of Widely Used Glaucoma Drug

Posted 19 Dec 2014 by

THURSDAY, Dec. 18, 2014 – Prostaglandin analogue eye drops – a common form of glaucoma drug – significantly reduce the risk of vision loss in patients with the eye disease, a new study finds. British researchers led by David Garway-Heath, of the Moorfields Eye Hospital and UCL Institute of Ophthalmology in London, tracked outcomes for more than 500 people newly diagnosed with open-angle glaucoma – the most common form of the disease and one of the leading causes of blindness. About 45 million people worldwide have this type of glaucoma, and the number is expected to rise to 53 million by 2020 and 80 million by 2040, according to the researchers. However, they found that the use of latanoprost – a form of prostaglandin analogue eye drops – reduced the risk of vision loss in these patients by more than 50 percent over two years, compared to those who received an inactive placebo. ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Xalatan, Latanoprost

Researchers Probe Molecular Cause for Glaucoma

Posted 11 Sep 2014 by

THURSDAY, Sept. 11, 2014 – A novel study of mice has shed new light on the molecular basis for glaucoma, which is a leading cause of blindness in the United States. Based on their findings, researchers from Northwestern University Feinberg School of Medicine in Chicago said they are working to develop eye drops that might one day cure the disease in people. "This is a big step forward in understanding the cause of the disease that steals the eyesight from 60 million people worldwide," study senior author Dr. Susan Quaggin, a Northwestern nephrologist, said in a university news release. "This gives us a foothold to develop new treatments." Glaucoma, which has no cure, blocks the drainage of fluid from the eye, which then builds up pressure that can damage the retina and the optic nerve. The vessel that is essential for proper drainage in the eye is known as Schlemm's canal. Using a ... Read more

Related support groups: Glaucoma

Could Time Spent Outdoors Raise Cataract, Glaucoma Risk?

Posted 4 Sep 2014 by

THURSDAY, Sept. 4, 2014 – Outdoor activities and sunlight reflected up into the eyes may increase the risk of a vision condition tied to cataracts and glaucoma, a new study suggests. There is some evidence that ultraviolet radiation contributes to the condition, called exfoliation syndrome (XFS), but the researchers behind the new study say those findings have been inconsistent. In order to learn more about the relationship between UV rays and XFS, researchers looked at 185 people in the United States and Israel with XFS and 178 people in the two countries without the eye condition. A team led by Dr. Louis Pasquale of Harvard Medical School and the Massachusetts Eye and Ear Infirmary analyzed the latitude where the participants lived and the average number of hours a week they spent outdoors. The investigators found that both factors appeared to affect a person's risk for XFS. Each ... Read more

Related support groups: Glaucoma, Cataract

Glaucoma Can Affect Babies, Too

Posted 2 Jul 2014 by

WEDNESDAY, July 2, 2014 – When Olivia Goree noticed something just "wasn't right" about her 6-week-old son's eyes, she trusted her instincts and took him to the doctor. What she never expected was the diagnosis: glaucoma. "I was really surprised," recalled Goree, who said she had only ever heard of the vision-robbing disease affecting older adults. And that's probably how most people think of glaucoma, since it's largely diagnosed in people older than 60. But rarely, the disease can strike infants and children. Glaucoma refers to a group of eye diseases in which fluid builds up in the eye, creating pressure that damages the optic nerve and leads to vision loss. In some cases, a baby will be born with glaucoma as part of a syndrome of birth defects, explained Dr. Robert Barnes, an ophthalmologist at Loyola University Medical Center in Maywood, Ill., who treated Goree's son, Christian. ... Read more

Related support groups: Glaucoma

Eye 'Training' May Help Restore Some Vision Lost to Glaucoma

Posted 22 Apr 2014 by

TUESDAY, April 22, 2014 – A new computerized eye-training program could upend the long-held belief that glaucoma-related vision loss is irreversible, a small study suggests. Daily "vision workouts" restored a significant degree of sight to a group of glaucoma patients by taking advantage of the brain's talent for learning new tricks, researchers said. "Glaucoma is a disease that slowly, over the course of years, damages the retina and optic nerve in the eye," said study lead author Bernhard Sabel, director of the Institute of Medical Psychology at the Otto-von-Guericke University of Magdeburg in Germany. "When tissue is damaged, vision impairments are the consequence," he added. Until now, vision loss was considered permanent. "All that could be done was to halt further progression," he said. Generally, vision loss from glaucoma begins with peripheral or side vision, leading to what ... Read more

Related support groups: Glaucoma

Glaucoma Drug May Help Reverse Obesity-Related Vision Loss

Posted 22 Apr 2014 by

TUESDAY, April 22, 2014 – A drug used to treat glaucoma eye disease can also help people with vision loss linked to obesity, a new study reveals. Researchers examined the effectiveness of the inexpensive drug, called acetazolamide (Diamox), in women and men with the condition known as "idiopathic intracranial hypertension." According to the researchers, the disorder primarily affects overweight women of reproductive age, and 5 percent to 10 percent of women with it suffer disabling vision loss. This study included 161 women and four men with idiopathic intracranial hypertension and mild vision loss. The investigators found that adding acetazolamide to a weight-loss plan featuring calorie reduction, lowered salt intake and exercise boosted vision improvement in these patients. Specifically, the vision of those who took the drug improved twice as much after six months compared to those ... Read more

Related support groups: Obesity, Glaucoma, Diamox, Acetazolamide, Diamox Sequels

Postmenopausal Estrogen Therapy Tied to Lower Glaucoma Risk

Posted 30 Jan 2014 by

THURSDAY, Jan. 30, 2014 – Women who take estrogen-only hormone-replacement therapy to relieve menopausal symptoms might also be reducing their risk for a common form of the eye disease glaucoma, according to new research. "Ours is one of the first ... studies to find estrogen-containing hormone-replacement therapy was associated with a reduction in glaucoma risk," said study researcher Dr. Joshua Stein, an assistant professor of ophthalmology at the University of Michigan. Other studies, however, have come up with conflicting results, Stein said. In his study, he looked at insurance-claims data for women aged 50 and older who were enrolled in a managed care plan for at least four years. The women visited an eye care provider at least twice from 2001 to 2009. He evaluated information on more than 152,000 women, about 60,000 of whom had at least one prescription for estrogen-only ... Read more

Related support groups: Estradiol, Premarin, Glaucoma, Estrace, Ethinyl Estradiol, Postmenopausal Symptoms, Vivelle, Vagifem, Estrace Vaginal Cream, Climara, Estring, Vivelle-Dot, Estradiol Patch, Premarin Vaginal, Evamist, Minivelle, Cenestin, Enjuvia, Femring, Estraderm

Risk of Glaucoma Blindness Drops by Half: Study

Posted 24 Jan 2014 by

FRIDAY, Jan. 24, 2014 – Better eye care seems to have brightened the long-term outlook for people with glaucoma. The likelihood of blindness in glaucoma patients 20 years after diagnosis has fallen by at least half in the last generation, according to a new study. Researchers analyzed the medical records of all the people 40 and older in Olmsted County, Minn., who were diagnosed with the eye disease between 1981 and 2000. The investigators compared these people to patients diagnosed with glaucoma between 1965 and 1980. The incidence of glaucoma did not change, but the risk of going blind in at least one eye fell from about 26 percent in the earlier group of patients to less than 14 percent in the newer group. The researchers also found that the annual incidence of glaucoma-caused blindness dropped by more than half. The results were published online in the January issue of the journal ... Read more

Related support groups: Glaucoma

Your Contact Lens Might Someday Dispense Eye Drugs

Posted 9 Dec 2013 by

MONDAY, Dec. 9, 2013 – Contact lenses that deliver glaucoma medication over long periods are getting closer to reality, say researchers working with laboratory animals. In their study, the lenses delivered the glaucoma drug latanoprost (brand name Xalatan) continuously to animals for a month. It's hoped that some day such lenses will replace eye drops now used to treat the eye disease, the researchers said. "In general, eye drops are an inefficient method of drug delivery that has notoriously poor patient adherence," study lead author Dr. Joseph Ciolino, a cornea specialist at the Massachusetts Eye and Ear Infirmary, said in an infirmary news release. "This contact lens design can potentially be used as a treatment for glaucoma and as a platform for other [eye] drug delivery applications." Glaucoma is the leading cause of irreversible blindness worldwide. The lenses, which appeared ... Read more

Related support groups: Glaucoma

'The Pill' Tied to Raised Risk of Glaucoma

Posted 18 Nov 2013 by

MONDAY, Nov. 18, 2013 – Taking birth control pills for more than three years may increase a woman's risk of developing the eye disease glaucoma, a new study suggests. The findings are from an investigation involving more than 3,400 women aged 40 and older who took part in the U.S. National Health and Nutrition Examination Survey between 2005 and 2008. "At this point, women who have taken oral contraceptives for three or more years should be screened for glaucoma and followed closely by an ophthalmologist, especially if they have any other existing risk factors," said lead researcher Dr. Shan Lin, professor of clinical ophthalmology at the University of California, San Francisco. Women who took birth control pills for longer than three years were twice as likely to have been diagnosed with glaucoma, according to the study. The findings were presented Monday at the annual meeting of the ... Read more

Related support groups: Birth Control, Contraception, Plan B, Mirena, Sprintec, NuvaRing, Implanon, Provera, Nexplanon, Depo-Provera, Tri-Sprintec, Ortho Tri-Cyclen, Yasmin, Microgestin Fe 1/20, Loestrin 24 Fe, Ortho Evra, Lutera, TriNessa, Mononessa, Plan B One-Step

Sleep Apnea May Be Linked to Glaucoma, Study Says

Posted 16 Aug 2013 by

FRIDAY, Aug. 16 – People with sleep apnea are at increased risk for glaucoma and should be screened for the eye disease, a new study suggests. Researchers examined the medical records of more than 1,000 people 40 and older who were diagnosed with sleep apnea between 2001 and 2004, and compared them to a "control" group of more than 6,000 people without sleep apnea. Those with sleep apnea were 1.67 times more likely to develop the most common type of glaucoma (open-angle glaucoma) within five years of their sleep apnea diagnosis than those in the control group, according to the study, published in the August issue of the journal Ophthalmology. Glaucoma is the second-leading cause of blindness worldwide. While previous research has found that glaucoma is more common among people with sleep apnea, this study concluded that sleep apnea is an independent risk factor for open-angle glaucoma. ... Read more

Related support groups: Glaucoma, Sleep Apnea

Page 1 2 3 Next

Ask a Question

Further Information

Related Condition Support Groups

Glaucoma (Open Angle), Glaucoma / Intraocular Hypertension, Glaucoma (Narrow Angle), Glaucoma with Pupillary Block, Eye Conditions

Related Drug Support Groups

Diamox, nadolol, Combigan, acetazolamide, Corgard, Diamox Sequels, methazolamide, Phospholine Iodide, Isopto Carbachol, view more... Pilopine-HS, Iopidine, carbachol, echothiophate iodide, Akarpine, Piloptic-1, Pilostat, Piloptic-1 / 2, Piloptic-2, Mitosol, Piloptic-6, Piloptic-4, Piloptic-3, Ocusert, apraclonidine, Pilagan with C Cap, Carboptic, Miostat, Pilocar, Isopto Carpine, brimonidine / timolol, Neptazane, mitomycin ophthalmic, Adsorbocarpine, Glauctabs, Ocu-Carpine